• Source:JND

JE Technology Desk: Google showcased numerous AI features at its mega Google I/O 2023 conference. Among a flurry of announcements was Med-PaLM 2, an AI tool to answer medical queries. To race ahead with the developments of AI undertaken by Microsoft, the company has already started testing the model to make it fit for use in clinics and medical institutions worldwide, according to The Wall Street Journal.

As per the search giant, in comparison to other algorithms trained on general data, Med-PaLM 2 can better handle conversations that discuss healthcare problems. It has been trained on inputs from medical exams. Google has been testing the model with an audience including Mayo Clinic since April, as per the sources cited in the report.

Also Read: AI In Healthcare: New AI Model Diagnosed Heart Attacks With 99% Accuracy; May Help Doctors In Future

It can answer medical queries, summarise and organise documents and health data. The model would not use patient data for training, and it will stay in an encrypted setting. Google shared with employees that the AI model as a medical consultant can "be of tremendous value in countries that have more limited access to doctors" in an email (in April) accessed by WSJ. However, it is still in the nascent stages of training, and we do not have a rollout date of the model yet.

The spark that ChatGPT ignited in 2022 is in the evolving stages as top tech companies have rolled out their AI innovations for the public. This has also framed the interests of the medical fraternity to inculcate emerging technology in work. Microsoft is also reportedly exploring opportunities in the medical sector and aims to utilise the OpenAI model to aid its endeavour.

Also Read: AI Model Could Soon Help Doctors Optimise Treatment Of Type 2 Diabetes-Induced Illness | Check Here

Besides Med-PaLM 2, the company axed the waitlist to use Bard and introduced AI tools for the business at I/O 2023. Duet AI for Workspace has been rolling out to users after the capabilities were showcased at I/O 2023.